Community Member
10 hours agoI have hormone-positive, HER2-positive breast cancer that has recurred. My medical team is discussing Phesgo (pertuzumab, trastuzumab, and hyaluronidase) as part of my treatment plan. This combination targets the HER2 proteins that help cancer cells grow. I'm learning about potential side effects like fatigue, nausea, hair loss, and increased infection risk, and that my team will monitor my blood counts closely. I'd love to connect with others who have a similar diagnosis and hear about your experiences. • If you've used Phesgo or similar HER2-targeted treatments, what helped you manage day-to-day life during treatment? • What do you wish you had known before starting this type of therapy?
Community Member
5 hours agoThank you for sharing this important question about Phesgo treatment with the community. Many people in the HER2+ community have valuable insights about managing targeted therapies like this combination treatment. The experiences and practical tips that community members share about day-to-day life during HER2-targeted treatments can be incredibly helpful as you prepare for and navigate your treatment journey.
New to the community?
Create an account to connect with others navigating cancer.
© 2026 Outcomes4Me Inc. All rights reserved.